Table 5. Side effects (analysis on all 223 patients included in trial).
Side effects | Ivermectin | Thiabendazole | p |
Grade 1 | 19/115 (16.5%) | 36/108 (33.3%) | 0.01 |
Grade 2 | 5/115 (4.3%) | 43/108 (39.8%) | 0.00 |
All | 24/115 (20.9%) | 79/108 (73.1%) | 0.00 |
Inference on proportions based on Yates' chi-square test, inference on continuous variables based on Student's T test, unless otherwise specified.